Fundz

Kronos Bio, Inc. reported raising $105 Million in an initial SEC Form D filing, from an offering of $105 Million

PRIVATEJul 15, 2019

Amount Raised

$105 Million

$105 Million sold, per SEC Form D (first sale Jul 15, 2019)

Round Type

Venture

San MateoBiotechnologyHealth CareTherapeutics

Quick answer

Kronos Bio raised $105 Million in a funding round, dated July 15, 2019. Kronos Bio is based in San Mateo, California, United States.

How much did Kronos Bio raise?
Kronos Bio raised $105 Million in a funding round on July 15, 2019.
What does Kronos Bio do?
Kronos Bio, Inc. is a clinical-stage company dedicated to developing small molecule therapeutics that address deregulated transcription, a hallmark of cancer and other diseases.
Where is Kronos Bio based and how big is it?
Kronos Bio is based in San Mateo, California, United States. Fundz records about 74 employees.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Kronos Bio that raised within 45 days of this round, from Fundz verified event records.

  • Landos Biopharma, Inc. raised $60M on August 23, 2019.
  • Werewolf Therapeutics raised $32M on August 15, 2019.
  • Vaccinex raised $14M on August 14, 2019.
  • Recursion Pharmaceuticals raised $122M on August 13, 2019.
  • Gallant raised $7M on August 5, 2019.
  • Solid Biosciences raised $60M on July 31, 2019.

Who to call at Kronos Bio, and when

A new round usually means Kronos Bio is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Kronos Bio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Kronos Bio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Kronos Bio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Kronos Bio

Location

1300 S. El Camino Real

San Mateo, California, United States

About

Kronos Bio, Inc. is a clinical-stage company dedicated to developing small molecule therapeutics that address deregulated transcription, a hallmark of cancer and other diseases. The company has a proprietary discovery engine that decodes complex transcription factor regulatory networks to identify druggable cofactors, yielding a preclinical pipeline along with two internally developed drug candidates. Kronos Bio is based in San Mateo, Calif., and has a research facility in Cambridge, Mass.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Kronos Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Kronos Bio's next move

See what Strategic adds

Kronos Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.